Andrew M. Nelson

This study evaluates the infection kinetics and Nirmatrelvir efficacy against Omicron subvariants in transgenic mice, finding that these subvariants show distinct viral dynamics but remain susceptible to the antiviral.

The paper develops a hybrid modeling pipeline to identify antitubercular compounds with favorable potency and pharmacokinetics, resulting in 12 promising candidates from a large compound library.

This paper demonstrates that adoptive transfer of CD49a+ CD4+ tissue resident memory T cells reverses established pulmonary fibrosis in mice by reducing collagen and improving lung function.